[1]
|
Steiner, G., Morita, S. and Vranic, M. (1980) Resistance to insulin but not to glucagon in lean human hypertri-glyceridemics. Diabetes, 29, 899-905
doi:10.2337/diabetes.29.11.899
|
[2]
|
Defronzo, R.A., Gunnarsson, R., Bjorkman, O., Olson, M. and Wahren, J. (1985) Effect of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent (type II) diabetes mellitus. Journal of Clinical Investigation, 76, 149-155. doi:10.1172/JCI111938
|
[3]
|
Reaven, G.M. (1988) Role of insulin resistance in human disease. Diabetes, 37, 1595-1607.
doi:10.2337/diabetes.37.12.1595
|
[4]
|
Kaplan, N.M. (1989) The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Archives of Internal Medicine, 149, 514-520.
doi:10.1001/archinte.1989.00390070054005
|
[5]
|
Reaven, G.M., Meheab, K., Villaume, C., Drouin, P. and Debry, G. (1983) Plasma glucose and insulin responses to oral glucose in nonobese subjects and patients with edo- geneous hypertriglyceridemia. Metabolism, 32, 447-450
doi:10.1016/0026-0495(83)90005-7
|
[6]
|
Yki-Jaervinen, H. and Taskinen, M.-R. (1988) Interrelationships among insulin’s antilipolytic and glucoregula- tory effects and plasma triglycerides in non-diabetic patients with endogenous hypertriglyceridemia. Diabetes, 37, 1271-1278. doi:10.2337/diabetes.37.9.1271
|
[7]
|
McKane, W.R., Stevens, A.B., Woods, R., Andrews, W.J., Henry, R.W. and Bell, P.M. (1990) The assessment of he- patic and peripheral insulin sensitivity in hypertriglyceri- demia. Metabolism, 39, 1240-1245
doi:10.1016/0026-0495(90)90177-E
|
[8]
|
Widén, E., Ekstrand, A., Saloranta, C., Franssila-Kallunki, A., Eriksson, J., Schalin-J?ntti, C. and Groop, L. (1992) Insulin resistance in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridemia. Diabetologia, 35, 1140-1145. doi:10.1007/BF00401367
|
[9]
|
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M.A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L. and Bevilacqua, S. (1987) Insulin resistance in essen- tial hypertension. The New England Journal of Medicine, 317, 350-357. doi:10.1056/NEJM198708063170605
|
[10]
|
Shen, D.C., Shieh, S.-M., Fuh, M.M.-T., Wu, D.-A., Chen, Y.-DI and Reaven. G.M. (1998) Resistance to insulin sti- mulated glucose uptake in patients with hypertension. The Journal of Clinical Endocrinology & Metabolism, 66, 580-583. doi:10.1210/jcem-66-3-580
|
[11]
|
Eliasson, B., Taskinen, M.R. and Smith, U. (1996) Long term use of nicotine gum is associated with hyperinsu- linemia and insulin resistance. Circulation, 94, 878-881.
doi:10.1161/01.CIR.94.5.878
|
[12]
|
Reaven, G.M. (1991) Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension: parallels between human disease and rodent models. Diabetes Care, 14, 195-202. doi:10.2337/diacare.14.3.195
|
[13]
|
Laakso, M., Edelman, S.V., Brechtel, G. and Baron, A.D. (1990) Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. Journal of Clinical Investigation, 85, 1844-1852. doi:10.1172/JCI114644
|
[14]
|
Roden, M., Price, T.B., Perseghin, G., Petersen, K.F., Rothman, D.L., Cline, G.W. and Shulman, G.I. (1996) Mechanism of free fatty acid-induced insulin resistance in humans. Journal of Clinical Investigation, 15, 2859-2865.
doi:10.1172/JCI118742
|
[15]
|
Boden, G. (1996) Fatty acids and insulin resistance. Dia- betes Care, 19, 394-395. doi:10.2337/diacare.19.4.394
|
[16]
|
Nuutila, P., Koivisto, V.A., Knuuti, J., Ruotsalainen, U., Ter?s, M., Haaparanta, M., Bergman, J., Solin, O., Voipio- Pulkki, L.M., Wegelius, U., et al. (1992) The glucose free fatty acid cycleoperates in human heart and skeletal mus- cle in vivo. Journal of Clinical Investigation, 89, 1767- 1744. doi:10.1172/JCI115780
|
[17]
|
Voipio-Pulkki, L.M., Nuutila, P., Knuuti, M.J., Ruotsa- lainen, U., Haaparanta, M., Ter?s, M., Wegelius, U. and Koivisto, V.A. (1993) Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by posi- tron emission tomography. Journal of Nuclear Medicine, 34, 2064-2067.
|
[18]
|
Nuutila, P., M?ki, M., Laine, H., Knuuti, M.J., Ruotsalai- nen, U., Luotolahti, M., Haaparanta, M., Solin, O., Jula, A., Koivisto, V.A., et al. (1995) Insulin action on heart and skeletal muscle glucose uptake in essential hyperten- sion. Journal of Clinical Investigation, 96, 1003-1009.
doi:10.1172/JCI118085
|
[19]
|
Yokoyama, I., Ohtake, T., Momomura, S., Yonekura, K., Yamada, N., Nishikawa, J., Sasaki, Y. and Omata, M. (1998) Organ specific insulin resistance in patients with non-insulin dependent diabetes mellitus and hypertension. Journal of Nuclear Medicine, 39, 884-889.
|
[20]
|
Ehrenkaufer, R.E., Potocki, J.F. and Jewett, D.M. (1989) Simple synthesis of F-18 labeled 2-fluoro-2-deoxy-D-glu- cose. Journal of Nuclear Medicine, 26, 477-485.
|
[21]
|
Ohtake, T., Kosaka, N., Watanabe, T., Yokoyama, I., Moritan, T., Masuo, M., Iizuka, M., Kozeni, K., Momose, T., Oku, S., Nishikawa, J., Sasaki, Y. and Iio, M. (1991) Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs. Journal of Nuclear Medicine, 32, 1432-1438.
|
[22]
|
Yokoyama, I., Inoue, Y., Moritan, T., Ohtomo, K. and Nagai, R. (2005) Measurement of skeletal muscle glucose utilization by dynamic 18F-FDG PET without arteial blood sampling. Nuclear Medicine Communications, 26, 31-37.
doi:10.1097/00006231-200501000-00006
|
[23]
|
Yokoyama, I., Ohtake, T., Momomura, S., Yonekura, K., Woo-Soo, S., Nishikawa, J., Sasaki, Y. and Omata, M. (1998) Hyperglycemia rather than insulin resistance is re- lated to coronary flow reserve in patients with non-insulin dependent diabetes mellitus. Diabetes, 47, 119-124.
doi:10.2337/diabetes.47.1.119
|
[24]
|
Capaldo, B., Lembo, G., Napoli, R., Rendina, V., Albano, G., Sacca, L. and Trimarco, B. (1991) Skeletal muscle is a primary site of insulin resistance in essential hyperten- sion. Metabolism, 40, 1320-1322.
doi:10.1016/0026-0495(91)90036-V
|
[25]
|
Natali, A., Quinones, G.A, Pecori, N., Sanna, G., Toschi, E. and Ferrannini, E. (1998) Vasodilation with sodium nitroprusside does not improve insulin action in essential hypertension. Hypertension, 31, 632-636.
doi:10.1161/01.HYP.31.2.632
|
[26]
|
Laine, H., Ykiarvinen, H., Kirvela, O., Tolvanen, T., Raitakari, M., Solin, O., Haaparanta, M., Knuuti, J. and Nuutila, P. (1998) Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. Journal of Clinical Investigation, 101, 1156-1162.
doi:10.1172/JCI1065
|
[27]
|
Paternostro, G., Camici, P.G., Lammerstma, A.A., Ma- rinho, N., Baliga, R.R., Kooner, J.S., Radda, G.K. and Ferrannini, E. (1996) Cardiac and skeletal muscle insulin resistance in patients with heart disease. Journal of Clinical Investigation, 98, 2094-2099.
doi:10.1172/JCI119015
|
[28]
|
Defronzo, R.A. and Ferrannini, E. (1991) Insulin resistance. A multifacted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173-194
doi:10.2337/diacare.14.3.173
|
[29]
|
Rodnick, K.J., Henriksen, E.J., James, D.E. and Holloszy, J.O. (1992) Exercise training, glucose transporters, and glucose transport in rat skeletal muscles. American Journal of Physiology, 262, C9-C14.
|
[30]
|
Matsui, H., Okumura, K., Kawakami, K., Hibino, M. and Ito, T. (1997) Improved insulin sensitivity by bezafibrate in rats: Relationship to fatty acid composition of skeletal muscle t3riglycerides. Diabetes, 46, 348-353.
doi:10.2337/diabetes.46.3.348
|
[31]
|
Rivellese, A.A., Maffettone, A., Iovine, C., DiMarino, L., Annuzzi, G., Mancini, M. and Ricardi, G. (1996) Long term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care, 19, 1207-1213.
doi:10.2337/diacare.19.11.1207
|
[32]
|
Matsuhisa, M., Shi, Z.Q., Wan, C., Lekas, M., Rodgers, C.D., Giacca, A., Kawamori, R. and Vranic, M. (1997) The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogs. Diabetes, 46, 224-231.
doi:10.2337/diabetes.46.2.224
|
[33]
|
Nestel, P.J., Pomeroy, S.E., Sasahara, T., Yamashita, T., Liang, Y.L., Dart, A.M., Jennings, G.L., Abbey, M. and Cameron, J.D. (1997) Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arte- riosclerosis, Thrombosis, and Vascular Biology, 17, 1163-1170.
|
[34]
|
Fujiwara, T., Yoshioka, S., Yoshioka, T., Ushiyama, I. and Horikoshi, H. (1988) Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes, 37, 1549-1558.
doi:10.2337/diabetes.37.11.1549
|
[35]
|
Iwamoto, Y., Kuzuya, T., Matsuda, A., Awata, T., Kuma-kura, S., Inooka, G. and Shiraishi, I. (1991) Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care, 14, 1083-1086. doi:10.2337/diacare.14.11.1083
|
[36]
|
Nolan, J.J., Ludvik, B., Beerdsen, P., Joyce, M. and Olefsky, J. (1994) Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. The New England Journal of Medicine, 331, 1188-1193.
doi:10.1056/NEJM199411033311803
|
[37]
|
Yokoyama, I., Yonekura, K., Ohtake, T., Yang, W., Shin, W.S., Yamada, N., Ohtomo, K. and Nagai, R. (2001) Troglitazone can improve impaired femoral muscle glucose utilization in type II diabetics with or without hypertension. Journal of Nuclear Medicine, 42, 1005-1010.
|